
	Where results make sense

Topic: AbioMed

In the News (Sat 26 Dec 09)

Northern Trust

Marvin Harrison

Peter Chernin

Gary Locke

Match Play

Penelope Cruz

Mickey Rourke

AR Rahman

Danny Boyle

Hugh Jackman

	Products Overview
		Abiomed is dedicated to finding ways to treat heart failure so that patients and physicians with have the most advanced, most successful, and most beneficial technology available.
		ABIOMED is also working on the next generation implantable replacement heart, the AbioCor II.
		Incorporating technology both from ABIOMED and Penn State, the AbioCor II is smaller and is being designed with a goal of five year reliability.
	www.abiomed.com /products/index.cfm (356 words)

	Abiomed seeks Wall Street's heart - The Boston Globe (via CobWeb/3.1 planetlab2.cs.unc.edu) (Site not responding. Last check: 2007-10-22)
		Abiomed also aims to increase to 14 from five the number of former nurses it employs to help hospitals use its pumps.
		Abiomed stopped looking for patients at two points during the trial to review data and make some design changes, including a new cuff for the AbioCor at the point where it is sewn into the patient's tissue, meant to minimize the buildup of blood clots, which can cause strokes.
		Abiomed's external pumps receive less attention than the artificial hearts but often are the most cost-effective way to cure patients.
	www.boston.com.cob-web.org:8888 /business/technology/biotechnology/articles/2004/06/21/abiomed_seeks_wall_streets_heart (1266 words)

	USATODAY.com - Firm's mission: Find solutions for heart problem (Site not responding. Last check: 2007-10-22)
		Abiomed Inc., the Massachusetts company that developed the artificial heart implanted in a Louisville patient, was set up in 1981 to find mechanical ways to help people with heart problems.
		David M. Lederman, Abiomed's founder, president and chief executive officer, said sales of the assist device established a network of hospitals and doctors familiar with the company, which laid the groundwork for acceptance of its artificial heart, which is called the AbioCor.
		Abiomed spokesman Ed Berger said the goal is to protect patient confidentiality, and to keep the surgical teams focused on patient care with no distractions from the media.
	www.usatoday.com /news/health/2001-07-03-heart-abiomed.htm (456 words)

	Abiomed expects 2Q revenue of $11M - Boston.com (via CobWeb/3.1 planetlab2.cs.unc.edu) (Site not responding. Last check: 2007-10-22)
		Medical-products company Abiomed Inc. on Thursday said it expects to report fiscal second-quarter revenue of about $11 million, short of analysts' expectations.
		Abiomed said the $11 million is a slight improvement over the $10.9 million reported for the year-ago period.
		Abiomed, which makes medical products designed to assist failing hearts, saw its shares fall $1, or 6.7 percent, to $14 in aftermarket trading on the INET electronic exchange.
	www.boston.com.cob-web.org:8888 /business/articles/2006/10/12/abiomed_expects_2q_revenue_of_11m (186 words)

	SEC Info - Abiomed Inc - 425 - Thoratec Cardiosystems Inc/MA - On 1/10/01 (Site not responding. Last check: 2007-10-22)
		ABIOMED's offer for Thermo Cardiosystems is a fixed $11.50 per share, with $1.50 in cash and $10.00 in ABIOMED common stock, subject to a cap on the maximum number of shares offered.
		ABIOMED is preparing for a clinical trial of its implantable replacement heart for the permanent support of patients needing ventricular replacement with focus on coronary heart disease patients and those congestive heart failure patients who cannot be adequately assisted by a ventricular assist device.
		ABIOMED, its directors and certain of its executive officers may be considered participants in any solicitation of proxies made in connection with the proposed business combination.
	www.secinfo.com /dRqWm.4S1.htm (1252 words)

	Abiomed
		Abiomed to present at Thomas Weisel Partners Healthcare Conference
		Abiomed to present at Canaccord Adams 26th Annual Summer Seminar 2006
		Abiomed announces fiscal first quarter 2007 results with revenues up 55% to $13 million
	www.abiomed.com (67 words)

	Penn State News
		ABIOMED announced today that it has entered into agreements to acquire the exclusive rights to Penn State's implantable replacement heart (the Penn State Heart) as well as the assets of BeneCor Heart Systems, Inc., a company recently created to commercialize the Penn State Heart.
		ABIOMED will also have access to future advances in related implantable replacement heart technology generated by the Penn State research and development team.
		ABIOMED intends to pursue the commercialization of the Penn State Heart at its Danvers, Massachusetts facility.
	www.psu.edu /ur/2000/abiomed.html (571 words)

	ABIOMED, Inc. :: ABIOMED Announces Third Quarter of Fiscal 2006 Financial Results (Site not responding. Last check: 2007-10-22)
		ABIOMED added two new sales representatives in the U.S. This brings ABIOMED's total sales and clinical team to 30 in the U.S. and 10 in Europe.
		ABIOMED is currently the only company with FDA labeling on ventricular assist devices for all potentially recoverable indications.
		ABIOMED's devices encourage recovery and are easier to implant, utilizing cannula inserted through a small incision, rather than more traumatic bridge-to-transplant devices that core the ventricles and require heart-lung machines for implantation.
	sev.prnewswire.com /biotechnology/20060202/NYTH07102022006-1.html (913 words)

	ABIOMED BVS 5000 - Texas Heart Institute - Heart Assist Devices
		The ABIOMED BVS 5000™ is used worldwide for temporary left, right, or biventricular (both ventricles) support in patients with potentially reversible heart failure.
		The BVS 5000 underwent preclinical studies at the Texas Heart Institute (THI) from 1986 to 1988 and was introduced for use in patients at THI in 1988.
		309), and "Five-year clinical experience with Abiomed BVS 5000 as a ventricular assist device for cardiac failure," which appears in Volume 16 (2001) of the publication Perfusion (p.
	www.texasheartinstitute.org /Research/Devices/abiomed.cfm (483 words)

	ABIOMED jobs - GetTheJob.com
		ABIOMED is seeking an experienced Associate General Counsel to assist the General Counsel in protecting the needs of the organizations legal interests and maintaining its operations within the scope established by the law.Principle Duties and Responsibilities: Provide continuous support for SEC...
		ABIOMED is seeking an experienced Program Manager to join our dynamic engineering group and lead the development of AbioCor, the world's first completely self-contained replacement heart.
		ABIOMED is seeking an experienced, hands on, Senior Electronics Design Engineer to join their engineering group.
	www.getthejob.com /ABIOMED_jobs.aspx (720 words)

	Abiomed - Job Interview Report
		I was informed about job openings at Abiomed through a relative, who is a software development manager.
		I sent in my resume through the Abiomed website, and I also sent it to my relative to push to the right people inside.
		Abiomed had two potential positions for me, one as a marketing manager, and another as a clinical manager.
	www.puvu.com /Reports/Abiomed-1791092.html (301 words)

	ABIOMED AB5000 Circulatory Support System - Texas Heart Institute
		The Abiomed AB5000 Circulatory Support System is a short-term mechanical circulatory support system that can provide left, right, or biventricular support for patients whose hearts have failed but have the potential for recovery.
		The pump, connected to cannulas placed in the heart, fills with blood by gravitational force and by vacuum assistance from the drive console.
		The cannulas and drive console are the same as those used for the ABIOMED BVS-5000.
	www.tmc.edu /thi/abiomedab5000.html (269 words)

	Abiomed Tubing System: FDA Approved - Medgadget - www.medgadget.com
		Abiomed (pronounced "AB'-EE-O-MED"), maker of ventricular assist devices, has recently received US FDA approval for their integrated cannula tubing system.
		Abiomed's new cannula system provides an enhanced benefit since patients will not require a second sternotomy during off-pump explantations.
		The new cannula system consists of a 42 French cannula, surgical sewing cuff and an inline connector for precise implantation and reduced blood loss for patients in acute heart failure.
	www.medgadget.com /archives/2006/07/abiomed_tubing.html (246 words)

	Guide to Collections Relating to the History of Artificial Internal Organs
		ABIOMED is engaged in the research, development, manufacture and sale of cardiac assist and heart replacement technologies.
		Their products include the ABIOMED BVSÂ® 5000, cardiac support system, that provides a patient's failing heart with full circulatory assistance while allowing the heart to rest, heal and recover its function.
		ABIOMED is currently developing the AbioCor Implantable Replacement Heart, a totally implantable, battery-powered heart replacement device intended for patients with irreparably damaged hearts who are at risk of death due to acute myocardial infarction, chronic ischemic disease or some form of end-stage congestive heart failure, but whose vital organs otherwise remain viable.
	www.nlm.nih.gov /hmd/manuscripts/asaio/abiomed.html (192 words)

	Abiomed, Inc. Jobs - Employment Opportunities at Monster.com (Site not responding. Last check: 2007-10-22)
		Based in Danvers, Massachusetts, ABIOMED, Inc. (pronounced "AB'-EE-O-MED") is a leading developer, manufacturer and marketer of medical products designed to assist or replace the pumping function of the failing heart.
		ABIOMED, which currently sells the BVS® 5000 Biventricular Support System and the AB5000(tm) Circulatory Support System, is the market leader in devices for the temporary support of patients with failing but potentially recoverable hearts.
		In September 2004, ABIOMED applied for initial FDA market approval for the AbioCor® Implantable Replacement Heart to treat a defined subset of irreversible end-stage heart failure patients under a Humanitarian Device Exemption.
	company.monster.com /abiomed (114 words)

	Medcompare - Cardiovascular News : FDA Advisory Panel Voted ABIOMED's AbioCor® Submission Did Not Yet Meet HDE ...
		ABIOMED is committed to working with the FDA to submit additional data regarding patients' anti-coagulation and quality of life information.
		ABIOMED initially submitted the AbioCor for marketing approval under HDE to the FDA in September 2004.
		ABIOMED currently manufactures and sells the AB5000 Circulatory Support System and the BVS® 5000 Biventricular Support System for the temporary support of all patients with failing but potentially recoverable hearts.
	www.medcompare.com /news.asp?newsid=85379 (694 words)

	ABIOMED News
		ABIOMED News continually updated from thousands of sources around the net.
		Abiomed Inc. finally has a product to show from its more than $100 million investment in the dream that inspired the company's founding a quarter-century ago: to develop the world's first fully implantable...
		Abiomed otrzymuje zezwolenie agencji FDA na stosowanie urz...dzenia...
	www.topix.net /com/abmd (229 words)

	News: Abiomed to Present at Needham & Company's Fifth Annual Biotechnology and Medical Technology Conference. Genetic ...
		Abiomed, Inc. (NASDAQ: ABMD) announced today that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at Needham & Company's Fifth Annual Biotechnology and Medical Technology Conference on June 14, at 11:30 a.m.
		Based in Danvers, Massachusetts, ABIOMED, Inc. is a leading developer, manufacturer and marketer of medical products designed to assist or replace the pumping function of the failing heart.
		ABIOMED currently manufactures and sells the AB5000(TM) Circulatory Support System and the BVS(R) 5000 Biventricular Support System for the temporary support of all patients with failing but potentially recoverable hearts.
	www.genengnews.com /news/bnitem.aspx?name=2273975 (349 words)

	LH - News 2006 - ABIOMED Selects LH as Center of Excellence
		Samuels has more than 10 years experience working with VADs that are designed to give temporary support while the heart recovers from acute heart failure or in some cases serve as a bridge to heart transplant.
		ABIOMED CEO and President Mike Minogue will present Lankenau with the Center of Excellence Award during a ceremony on Tuesday, December 20, beginning at 11 am.
		As an ABIOMED Center of Excellence, Lankenau Hospital will help set standards for physician training on the BVS5000 and AB5000 Circulatory Support Systems, and will share best practices related to VAD implantation and patient care.
	www.mainlinehealth.org /lh/news_12389.asp (477 words)

	Business Ticker - The Boston Globe
		Abiomed is targeting men -- but not precluding women -- with heart failure who are too sick for a heart transplant, have exhausted other options and are likely to die within a month.
		In 2005, an FDA panel of outside experts voted against recommending Abiomed be given permission to sell the device in limited numbers.
		Abiomed eventually hopes 10 medical centers would be equipped to implant the hearts.
	www.boston.com /business/ticker/2006/09/mass_company_ge.html (550 words)

	Bellin Health Systems » Includes » Abiomed BVS 5000 (Site not responding. Last check: 2007-10-22)
		Bellin Health is now using the ABIOMED BVS 5000 Bi-Ventricular Support (BVS) Systems to help a failing heart to rest, heal and recover its normal function.
		The ABIOMED cardiac support system represents Bellin Health's continued effort to make the most advanced heart treatment options available to the people of Northeast Wisconsin and Upper Michigan.
		According to ABIOMED, the BVS device can improve patient survival rates 60 percent for postcardiotomy, 71 percent of acute myocardial infarction and 75 percent for viral myocarditis.
	www.bellin.org /services/cardiac/abiomed.shtml (472 words)

	Interview with Edward Berger, ABIOMED, Inc.: TWST
		Berger: ABIOMED was founded more than 22 years ago for the express purpose of developing a totally implantable artificial human heart.
		Berger: ABIOMED was the first to enter the mechanical heart assist marketplace with the BVS 5000.
		It is the most frequently used circulatory support system in the country, and is appropriate for any form of acute but potentially recoverable heart failure and relatively short periods of support ranging up to about two weeks.
	www.twst.com /notes/articles/waj609.html (796 words)

	BioSpace News for Abiomed (Site not responding. Last check: 2007-10-22)
		ABIOMED, Inc (NASDAQ:ABMD - news) reported that the 74 year old male who was the recipient of an AbioCor(TM) Implantable Replacement Heart on October 17, 2001 died yesterday at the UCLA Medical Center.
		ABIOMED, Inc. (NASDAQ:ABMD - news) announced today that it has received permission from the U. Food and Drug Administration to move forward, without interruption, to enroll an additional five (5) patients in the initial U.S. clinical trial of the AbioCor(TM) Implantable Replacement Heart.
		ABIOMED, Inc. (NASDAQ:ABMD - news) announced today that The Heart Lung Center Utrecht (Utrecht, the Netherlands) and Lund University Hospital (Lund, Sweden) have been selected to participate in the European clinical trial of the AbioCor(TM) Implantable Replacement Heart.
	www.acor.org /drugs/pipeline/companies/news/2933.news.orig (565 words)

	(Newstrends) Abiomed to Acquire Impella (MDDI archive, Jul 05)
		Abiomed is best known for its artificial hearts.
		The acquisition would give Abiomed access to patients who have severe heart problems but don’t need a new heart.
		The deal is expected to entail $1.8 million in cash in addition to 4.04 million shares of Abiomed common stock.
	www.devicelink.com /mddi/archive/05/07/004.html (194 words)

	Careers at Abiomed :: Interview with Abiomed
		Abiomed, Inc. engages in the development, manufacture, and marketing of medical products to assist or replace the pumping function of the failing heart.
		ABIOMED manufactures and sells the AB5000 Circulatory Support System and the BVS 5000 Biventricular Support System for the temporary support of patients with failing but potentially recoverable hearts.
		Abiomed blogs - see if any current employees of Abiomed are blogging and what they are writing.
	www.interviewat.com /abiomed (178 words)

	RWJUH Recognized as an ABIOMED Center of Excellence, Robert Wood Johnson University Hospital, New Brunswick, NJ, 08903
		RWJUH Recognized as an ABIOMED Center of Excellence, Robert Wood Johnson University Hospital, New Brunswick, NJ, 08903
		NEW BRUNSWICK, NJ - ABIOMED, a leading developer and manufacturer of medical products that assist the pumping function of failing hearts, has selected Robert Wood Johnson University Hospital in New Brunswick as a "Center of Excellence" for its cardiac program.
		ABIOMED currently manufactures and sells the AB5000TM Circulatory Support System and the BVSÂ® 5000 Biventricular Support System for the temporary support of all patients with failing but potentially recoverable hearts.
	www.rwjuh.edu /news/abiomed_coe.html (715 words)

	Pharmacy Choice - Pharmaceutical News - ABIOMED Announces Execution of a Definitive Agreement to Acquire Impella ...
		In addition, ABIOMED may make additional contingent payments to Impella shareholders based on stock price performance, unit sales and FDA approval milestones.
		ABIOMED, which currently sells the BVS(R) 5000 Biventricular Support System and the AB5000(TM) Circulatory Support System, is the market leader in devices for the temporary support of patients with failing but potentially recoverable hearts.
		ABIOMED is also pursuing initial FDA market approval for the AbioCor(R) Implantable Replacement Heart under a Humanitarian Device Exemption to treat a defined subset of irreversible end-stage heart failure patients.
	www.pharmacychoice.com /News/article.cfm?Article_ID=2206 (1179 words)

	ABIOMED Article Archives by KeepMedia (Site not responding. Last check: 2007-10-22)
		This change impacts ABIOMED's AB5000 and BVS 5000 devices in procedures with both implant and explant reimbursement codes, which will now map to DRG 103.
		ABIOMED to Present at Adams Harkness' 25th Annual Summer Seminar
		Heart failure patients who are too weak for a human transplant might move a step closer today to gaining access to the first fully self-contained implanted artificial heart.
	www.topix.net /com/abmd/keepmedia (443 words)

Try your search on: Qwika (all wikis)